14657064Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW, INVEST InvestigatorsJAMAAdrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Coronary Artery Disease; Hydrochlorothiazide; Hypertension; Indoles; Sodium Chloride Symporter Inhibitors; VerapamilAged; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Middle Aged; Treatment OutcomeA calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA. 2003 Dec 03; 290(21):2805-16.JAMA2003-12-03T00:00:002003A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.prns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000368Living Beings1341183530.294764AgedD001794DisordersPhysiology27311430.654225Blood PressureD000319Chemicals & Drugs591520.904003Adrenergic beta-AntagonistsD000806Chemicals & Drugs622310.875905Angiotensin-Converting Enzyme InhibitorsD000959Chemicals & Drugs905210.70252Antihypertensive AgentsD001262Chemicals & Drugs4340.978467AtenololD004232Chemicals & DrugsPhysiology331240.942324DiureticsD003324Disorders1163470.700518Coronary Artery DiseaseD006973Disorders25811390.526672HypertensionD004359Procedures2748930.819188Drug Therapy, CombinationD007211Chemicals & Drugs1343180.849938IndolesD006852Chemicals & Drugs5760.954709HydrochlorothiazideD008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedAuthorship 2393413D005260Physiology1992444050.191167FemaleD014700Chemicals & Drugs26480.977914VerapamilD006801Living Beings2262862810.130052HumansD008297Physiology1931408600.201617MaleD016896Concepts & Ideas101179490.402389Treatment Outcome0.06113920.06113921authors10.2521has subject areaD049993Chemicals & Drugs8430.973633Sodium Chloride Symporter InhibitorsD002121Chemicals & Drugs722030.912284Calcium Channel BlockersD006339DisordersPhysiology2094920.81139Heart RateUniversity of ChicagoGeorgeBakris0GBoa7McCszMknJtY0fp/Cv/+94=George Bakris41.78927490000000-87.601250000000001393Bakris, GeorgeProfessortrue1ProfessorProfessorMedicine-Endocrinology